Last reviewed · How we verify

Phoslo — Competitive Intelligence Brief

Phoslo (CALCIUM ACETATE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: calcium acetate. Area: Hematology.

marketed calcium acetate Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Phoslo (CALCIUM ACETATE) — Fresenius Medcl Care. Phoslo works by increasing calcium levels in the blood to treat conditions related to low calcium.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Phoslo TARGET CALCIUM ACETATE Fresenius Medcl Care marketed calcium acetate 1982-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (calcium acetate class)

  1. Fresenius Medcl Care · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Phoslo — Competitive Intelligence Brief. https://druglandscape.com/ci/calcium-acetate. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: